Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.

Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME, TB Trials Consortium

Open source

DOI: 10.5588/ijtld.14.0829
Published: 2015 Sep
Container: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5588/ijtld.14.0829,
  title = {Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.},
  author = {Bliven-Sizemore EE and Sterling TR and Shang N and Benator D and Schwartzman K and Reves R and Drobeniuc J and Bock N and Villarino ME and TB Trials Consortium},
  year = {2015},
  journal = {The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease},
  doi = {10.5588/ijtld.14.0829},
  url = {https://doi.org/10.5588/ijtld.14.0829}
}

RIS

TY  - JOUR
TI  - Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
AU  - Bliven-Sizemore EE
AU  - Sterling TR
AU  - Shang N
AU  - Benator D
AU  - Schwartzman K
AU  - Reves R
AU  - Drobeniuc J
AU  - Bock N
AU  - Villarino ME
AU  - TB Trials Consortium
PY  - 2015
JO  - The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
DO  - 10.5588/ijtld.14.0829
UR  - https://doi.org/10.5588/ijtld.14.0829
ER  -

APA

EE, B., TR, S., N, S., D, B., K, S., R, R., J, D., N, B., ME, V., & Consortium, T. T. (2015). Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.14.0829

Source records

pubmed · retrieved 2026-09-26T16:14:00.285Z